← All trials
NCT05118789
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2021
- Primary completion
- Oct 31, 2025
- Completion date
- Oct 31, 2026
- First posted
- Nov 12, 2021
- Last posted
- Nov 15, 2021
- Enrollment
- 246
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Nuvalent Inc.Lead sponsor
- Nuvalent Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.